Elite Pharmaceuticals, Inc. (ELTP)
0.2286
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Elite Pharmaceuticals Profit Margin (Quarterly) : 18.27% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.27% |
| March 31, 2026 | 45.31% |
| December 31, 2025 | 58.86% |
| September 30, 2025 | 37.73% |
| June 30, 2025 | -14.63% |
| March 31, 2025 | 53.12% |
| December 31, 2024 | -75.83% |
| September 30, 2024 | -58.45% |
| June 30, 2024 | 3.28% |
| March 31, 2024 | 18.53% |
| December 31, 2023 | 4.55% |
| September 30, 2023 | |
| June 30, 2023 | 12.71% |
| March 31, 2023 | -14.23% |
| December 31, 2022 | 32.11% |
| September 30, 2022 | 17.65% |
| June 30, 2022 | 3.99% |
| March 31, 2022 | 31.66% |
| December 31, 2021 | 25.44% |
| September 30, 2021 | 21.00% |
| June 30, 2021 | 33.86% |
| March 31, 2021 | -10.98% |
| December 31, 2020 | 33.28% |
| September 30, 2020 | 33.54% |
| June 30, 2020 | 14.29% |
| Date | Value |
|---|---|
| March 31, 2020 | 18.94% |
| December 31, 2019 | -36.81% |
| September 30, 2019 | -34.43% |
| June 30, 2019 | 8.33% |
| March 31, 2019 | -198.2% |
| December 31, 2018 | -87.02% |
| September 30, 2018 | -189.5% |
| June 30, 2018 | -77.86% |
| March 31, 2018 | -177.2% |
| December 31, 2017 | -19.33% |
| September 30, 2017 | |
| June 30, 2017 | -127.4% |
| March 31, 2017 | -236.3% |
| December 31, 2016 | 71.52% |
| September 30, 2016 | |
| June 30, 2016 | -32.06% |
| March 31, 2016 | |
| December 31, 2015 | -1.69K% |
| September 30, 2015 | -259.7% |
| June 30, 2015 | |
| March 31, 2015 | -734.5% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -378.9% |
| March 31, 2014 | -3.06K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Daré Bioscience, Inc. | -1.59K% |
| Eton Pharmaceuticals, Inc. | 30.80% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 72.04% |
| Return on Assets | 44.66% |
| Return on Invested Capital | 66.87% |
| Gross Profit Margin (Quarterly) | 40.61% |
| Operating Margin (Quarterly) | 23.27% |
| Return on Net Operating Assets | 63.98% |